Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Charles E Inturrisi

Showing results (11-20 of 63) with videos related to

Pageof 7
Sort By:
Brain Research. Developmental Brain Research|April 25, 2003
The clinically available NMDA receptor antagonist dextromethorphan attenuates acute morphine withdrawal in the neonatal ratHongbo Zhu, Shirzad Jenab, Kathy L Jones, et al.
Anesthesiology Clinics|May 22, 2016
Using Chronic Pain Outcomes Data to Improve OutcomesNeel Mehta, Charles E Inturrisi, Susan D Horn, et al.
The Journal of Pain|December 6, 2005
Pharmacokinetics and effects of 17beta-estradiol and progesterone implants in ovariectomized ratsChristy A Mannino, Samantha M South, Charles E Inturrisi, et al.
Journal of Pain and Symptom Management|July 10, 2007
The successful use of parenteral methadone in a patient with a prolonged QTc intervalRyuichi Sekine, Eugenie A M T Obbens, Nessa Coyle, et al.
The Journal of Pain|December 5, 2006
Estradiol replacement in ovariectomized rats is antihyperalgesic in the formalin testChristy A Mannino, Samantha M South, Vanya Quinones-Jenab, et al.
Cellular and Molecular Neurobiology|May 12, 2021
Understanding Opioid Actions, Pain and Analgesia: A Tribute to Dr. Gavril PasternakKelly M Standifer, Charles E Inturrisi, Kathleen M Foley, et al.
Journal of Pain and Symptom Management|August 9, 2003
Parenteral methadone: an essential medication for the treatment of painPaolo L Manfredi, Kathleen M Foley, Richard Payne, et al.
Neuropharmacology|December 8, 2022
Ca<sub>v</sub>1.3 L-type Ca<sup>2+</sup> channel-activated CaMKII/ERK2 pathway in the ventral tegmental area is required for cocaine conditioned place preferenceArlene Martínez-Rivera, Jin Hao, Richard Rice, et al.
Pain|December 17, 2009
N-Methyl-D-aspartate receptor (NMDAR) independent maintenance of inflammatory painAmanda R Weyerbacher, Qinghao Xu, Cristina Tamasdan, et al.
The Journal of Pharmacology and Experimental Therapeutics|September 25, 2004
An antisense oligonucleotide to the N-methyl-D-aspartate (NMDA) subunit NMDAR1 attenuates NMDA-induced nociception, hyperalgesia, and morphine toleranceNaohito Shimoyama, Megumi Shimoyama, Antonia M Davis, et al.
Pageof 7

Showing results (11-20 of 63) with videos related to

Sort By:
Pageof 7
Brain Research. Developmental Brain Research|April 25, 2003
The clinically available NMDA receptor antagonist dextromethorphan attenuates acute morphine withdrawal in the neonatal ratHongbo Zhu, Shirzad Jenab, Kathy L Jones, et al.
Anesthesiology Clinics|May 22, 2016
Using Chronic Pain Outcomes Data to Improve OutcomesNeel Mehta, Charles E Inturrisi, Susan D Horn, et al.
The Journal of Pain|December 6, 2005
Pharmacokinetics and effects of 17beta-estradiol and progesterone implants in ovariectomized ratsChristy A Mannino, Samantha M South, Charles E Inturrisi, et al.
Journal of Pain and Symptom Management|July 10, 2007
The successful use of parenteral methadone in a patient with a prolonged QTc intervalRyuichi Sekine, Eugenie A M T Obbens, Nessa Coyle, et al.
The Journal of Pain|December 5, 2006
Estradiol replacement in ovariectomized rats is antihyperalgesic in the formalin testChristy A Mannino, Samantha M South, Vanya Quinones-Jenab, et al.
Cellular and Molecular Neurobiology|May 12, 2021
Understanding Opioid Actions, Pain and Analgesia: A Tribute to Dr. Gavril PasternakKelly M Standifer, Charles E Inturrisi, Kathleen M Foley, et al.
Journal of Pain and Symptom Management|August 9, 2003
Parenteral methadone: an essential medication for the treatment of painPaolo L Manfredi, Kathleen M Foley, Richard Payne, et al.
Neuropharmacology|December 8, 2022
Ca<sub>v</sub>1.3 L-type Ca<sup>2+</sup> channel-activated CaMKII/ERK2 pathway in the ventral tegmental area is required for cocaine conditioned place preferenceArlene Martínez-Rivera, Jin Hao, Richard Rice, et al.
Pain|December 17, 2009
N-Methyl-D-aspartate receptor (NMDAR) independent maintenance of inflammatory painAmanda R Weyerbacher, Qinghao Xu, Cristina Tamasdan, et al.
The Journal of Pharmacology and Experimental Therapeutics|September 25, 2004
An antisense oligonucleotide to the N-methyl-D-aspartate (NMDA) subunit NMDAR1 attenuates NMDA-induced nociception, hyperalgesia, and morphine toleranceNaohito Shimoyama, Megumi Shimoyama, Antonia M Davis, et al.
Pageof 7